世界の白血病治療市場規模・現状・予測2021-2027

【英語タイトル】Global Leukemia Screening Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR3402)・商品コード:QY21APR3402
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:95
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、白血病治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(骨髄穿刺・生検、胸部X線・胸部CATスキャン、脊髄タップ)、用途別市場規模(がん研究センター、診断研究所、クリニック、病院)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・白血病治療の市場動向
・企業の競争状況、市場シェア
・白血病治療の種類別市場規模(骨髄穿刺・生検、胸部X線・胸部CATスキャン、脊髄タップ)
・白血病治療の用途別市場規模(がん研究センター、診断研究所、クリニック、病院)
・白血病治療の北米市場規模2016-2027(アメリカ、カナダ)
・白血病治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・白血病治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・白血病治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・白血病治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Abbott、Abbvie、GE Healthcare、Siemens Healthcare、Philips Healthcare、Canon Medical Systems、Hitachi Medical Systems、Varian Medical Systems、Shimadzu Corporation)
・結論
【レポートの概要】

Currently, there are no standard leukemia screening methods recommended for regularly testing the leukemia affected patients. Specifically, no leukemia screening test has been reliably confirmed enough to detect the cancer in its early stages before the development of symptoms. Research and development for the leukemia screening is going on, and there is still much to be known about the exact causes of leukemia. As the understanding continues to increase, scientists are gaining a greater knowledge of possible ways to prevent, screen and treat this condition.
Leukemia is commonly caused because of the exposure to radiations, changing lifestyle, genetic mutations, and environmental conditions. Leukemia cases are more commonly found in adults and are observed to develop with aging. Thus, increasing aging population and high occurrence of leukemia are the factors rising the leukemia screening market. Also, novel advancements and R&D in the oncology sector and growing number of biotechnology companies, may also expected to boost the market growth.

Market Analysis and Insights: Global Leukemia Screening Market
The global Leukemia Screening market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Leukemia Screening market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Leukemia Screening market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Leukemia Screening market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Leukemia Screening market.

Global Leukemia Screening Scope and Market Size
Leukemia Screening market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Leukemia Screening market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Bone Marrow Aspiration and Biopsy
Chest X-Ray or Chest CAT Scan
Spinal Tap

Segment by Application
Cancer Research Centers
Diagnostic Laboratories
Clinics
Hospitals

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Abbvie
GE Healthcare
Siemens Healthcare
Philips Healthcare
Canon Medical Systems
Hitachi Medical Systems
Varian Medical Systems
Shimadzu Corporation

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leukemia Screening Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bone Marrow Aspiration and Biopsy
1.2.3 Chest X-Ray or Chest CAT Scan
1.2.4 Spinal Tap
1.3 Market by Application
1.3.1 Global Leukemia Screening Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer Research Centers
1.3.3 Diagnostic Laboratories
1.3.4 Clinics
1.3.5 Hospitals
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Leukemia Screening Market Perspective (2016-2027)
2.2 Leukemia Screening Growth Trends by Regions
2.2.1 Leukemia Screening Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Leukemia Screening Historic Market Share by Regions (2016-2021)
2.2.3 Leukemia Screening Forecasted Market Size by Regions (2022-2027)
2.3 Leukemia Screening Industry Dynamic
2.3.1 Leukemia Screening Market Trends
2.3.2 Leukemia Screening Market Drivers
2.3.3 Leukemia Screening Market Challenges
2.3.4 Leukemia Screening Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Leukemia Screening Players by Revenue
3.1.1 Global Top Leukemia Screening Players by Revenue (2016-2021)
3.1.2 Global Leukemia Screening Revenue Market Share by Players (2016-2021)
3.2 Global Leukemia Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Leukemia Screening Revenue
3.4 Global Leukemia Screening Market Concentration Ratio
3.4.1 Global Leukemia Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leukemia Screening Revenue in 2020
3.5 Leukemia Screening Key Players Head office and Area Served
3.6 Key Players Leukemia Screening Product Solution and Service
3.7 Date of Enter into Leukemia Screening Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Leukemia Screening Breakdown Data by Type
4.1 Global Leukemia Screening Historic Market Size by Type (2016-2021)
4.2 Global Leukemia Screening Forecasted Market Size by Type (2022-2027)

5 Leukemia Screening Breakdown Data by Application
5.1 Global Leukemia Screening Historic Market Size by Application (2016-2021)
5.2 Global Leukemia Screening Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Leukemia Screening Market Size (2016-2027)
6.2 North America Leukemia Screening Market Size by Type
6.2.1 North America Leukemia Screening Market Size by Type (2016-2021)
6.2.2 North America Leukemia Screening Market Size by Type (2022-2027)
6.2.3 North America Leukemia Screening Market Size by Type (2016-2027)
6.3 North America Leukemia Screening Market Size by Application
6.3.1 North America Leukemia Screening Market Size by Application (2016-2021)
6.3.2 North America Leukemia Screening Market Size by Application (2022-2027)
6.3.3 North America Leukemia Screening Market Size by Application (2016-2027)
6.4 North America Leukemia Screening Market Size by Country
6.4.1 North America Leukemia Screening Market Size by Country (2016-2021)
6.4.2 North America Leukemia Screening Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Leukemia Screening Market Size (2016-2027)
7.2 Europe Leukemia Screening Market Size by Type
7.2.1 Europe Leukemia Screening Market Size by Type (2016-2021)
7.2.2 Europe Leukemia Screening Market Size by Type (2022-2027)
7.2.3 Europe Leukemia Screening Market Size by Type (2016-2027)
7.3 Europe Leukemia Screening Market Size by Application
7.3.1 Europe Leukemia Screening Market Size by Application (2016-2021)
7.3.2 Europe Leukemia Screening Market Size by Application (2022-2027)
7.3.3 Europe Leukemia Screening Market Size by Application (2016-2027)
7.4 Europe Leukemia Screening Market Size by Country
7.4.1 Europe Leukemia Screening Market Size by Country (2016-2021)
7.4.2 Europe Leukemia Screening Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Leukemia Screening Market Size (2016-2027)
8.2 Asia-Pacific Leukemia Screening Market Size by Type
8.2.1 Asia-Pacific Leukemia Screening Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Leukemia Screening Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Leukemia Screening Market Size by Type (2016-2027)
8.3 Asia-Pacific Leukemia Screening Market Size by Application
8.3.1 Asia-Pacific Leukemia Screening Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Leukemia Screening Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Leukemia Screening Market Size by Application (2016-2027)
8.4 Asia-Pacific Leukemia Screening Market Size by Region
8.4.1 Asia-Pacific Leukemia Screening Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Leukemia Screening Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Leukemia Screening Market Size (2016-2027)
9.2 Latin America Leukemia Screening Market Size by Type
9.2.1 Latin America Leukemia Screening Market Size by Type (2016-2021)
9.2.2 Latin America Leukemia Screening Market Size by Type (2022-2027)
9.2.3 Latin America Leukemia Screening Market Size by Type (2016-2027)
9.3 Latin America Leukemia Screening Market Size by Application
9.3.1 Latin America Leukemia Screening Market Size by Application (2016-2021)
9.3.2 Latin America Leukemia Screening Market Size by Application (2022-2027)
9.3.3 Latin America Leukemia Screening Market Size by Application (2016-2027)
9.4 Latin America Leukemia Screening Market Size by Country
9.4.1 Latin America Leukemia Screening Market Size by Country (2016-2021)
9.4.2 Latin America Leukemia Screening Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Leukemia Screening Market Size (2016-2027)
10.2 Middle East & Africa Leukemia Screening Market Size by Type
10.2.1 Middle East & Africa Leukemia Screening Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Leukemia Screening Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Leukemia Screening Market Size by Type (2016-2027)
10.3 Middle East & Africa Leukemia Screening Market Size by Application
10.3.1 Middle East & Africa Leukemia Screening Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Leukemia Screening Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Leukemia Screening Market Size by Application (2016-2027)
10.4 Middle East & Africa Leukemia Screening Market Size by Country
10.4.1 Middle East & Africa Leukemia Screening Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Leukemia Screening Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Leukemia Screening Introduction
11.1.4 Abbott Revenue in Leukemia Screening Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Abbvie
11.2.1 Abbvie Company Details
11.2.2 Abbvie Business Overview
11.2.3 Abbvie Leukemia Screening Introduction
11.2.4 Abbvie Revenue in Leukemia Screening Business (2016-2021)
11.2.5 Abbvie Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Details
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Leukemia Screening Introduction
11.3.4 GE Healthcare Revenue in Leukemia Screening Business (2016-2021)
11.3.5 GE Healthcare Recent Development
11.4 Siemens Healthcare
11.4.1 Siemens Healthcare Company Details
11.4.2 Siemens Healthcare Business Overview
11.4.3 Siemens Healthcare Leukemia Screening Introduction
11.4.4 Siemens Healthcare Revenue in Leukemia Screening Business (2016-2021)
11.4.5 Siemens Healthcare Recent Development
11.5 Philips Healthcare
11.5.1 Philips Healthcare Company Details
11.5.2 Philips Healthcare Business Overview
11.5.3 Philips Healthcare Leukemia Screening Introduction
11.5.4 Philips Healthcare Revenue in Leukemia Screening Business (2016-2021)
11.5.5 Philips Healthcare Recent Development
11.6 Canon Medical Systems
11.6.1 Canon Medical Systems Company Details
11.6.2 Canon Medical Systems Business Overview
11.6.3 Canon Medical Systems Leukemia Screening Introduction
11.6.4 Canon Medical Systems Revenue in Leukemia Screening Business (2016-2021)
11.6.5 Canon Medical Systems Recent Development
11.7 Hitachi Medical Systems
11.7.1 Hitachi Medical Systems Company Details
11.7.2 Hitachi Medical Systems Business Overview
11.7.3 Hitachi Medical Systems Leukemia Screening Introduction
11.7.4 Hitachi Medical Systems Revenue in Leukemia Screening Business (2016-2021)
11.7.5 Hitachi Medical Systems Recent Development
11.8 Varian Medical Systems
11.8.1 Varian Medical Systems Company Details
11.8.2 Varian Medical Systems Business Overview
11.8.3 Varian Medical Systems Leukemia Screening Introduction
11.8.4 Varian Medical Systems Revenue in Leukemia Screening Business (2016-2021)
11.8.5 Varian Medical Systems Recent Development
11.9 Shimadzu Corporation
11.9.1 Shimadzu Corporation Company Details
11.9.2 Shimadzu Corporation Business Overview
11.9.3 Shimadzu Corporation Leukemia Screening Introduction
11.9.4 Shimadzu Corporation Revenue in Leukemia Screening Business (2016-2021)
11.9.5 Shimadzu Corporation Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Leukemia Screening Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bone Marrow Aspiration and Biopsy
Table 3. Key Players of Chest X-Ray or Chest CAT Scan
Table 4. Key Players of Spinal Tap
Table 5. Global Leukemia Screening Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Leukemia Screening Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Leukemia Screening Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Leukemia Screening Market Share by Regions (2016-2021)
Table 9. Global Leukemia Screening Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Leukemia Screening Market Share by Regions (2022-2027)
Table 11. Leukemia Screening Market Trends
Table 12. Leukemia Screening Market Drivers
Table 13. Leukemia Screening Market Challenges
Table 14. Leukemia Screening Market Restraints
Table 15. Global Leukemia Screening Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Leukemia Screening Market Share by Players (2016-2021)
Table 17. Global Top Leukemia Screening Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leukemia Screening as of 2020)
Table 18. Ranking of Global Top Leukemia Screening Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Leukemia Screening Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Leukemia Screening Product Solution and Service
Table 22. Date of Enter into Leukemia Screening Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Leukemia Screening Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Leukemia Screening Revenue Market Share by Type (2016-2021)
Table 26. Global Leukemia Screening Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Leukemia Screening Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Leukemia Screening Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Leukemia Screening Revenue Market Share by Application (2016-2021)
Table 30. Global Leukemia Screening Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Leukemia Screening Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Leukemia Screening Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Leukemia Screening Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Leukemia Screening Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Leukemia Screening Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Leukemia Screening Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Leukemia Screening Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Leukemia Screening Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Leukemia Screening Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Leukemia Screening Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Leukemia Screening Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Leukemia Screening Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Leukemia Screening Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Leukemia Screening Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Leukemia Screening Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Leukemia Screening Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Leukemia Screening Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Leukemia Screening Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Leukemia Screening Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Leukemia Screening Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Leukemia Screening Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Leukemia Screening Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Leukemia Screening Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Leukemia Screening Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Leukemia Screening Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Leukemia Screening Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Leukemia Screening Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Leukemia Screening Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Leukemia Screening Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Leukemia Screening Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Leukemia Screening Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Company Details
Table 63. Abbott Business Overview
Table 64. Abbott Leukemia Screening Product
Table 65. Abbott Revenue in Leukemia Screening Business (2016-2021) & (US$ Million)
Table 66. Abbott Recent Development
Table 67. Abbvie Company Details
Table 68. Abbvie Business Overview
Table 69. Abbvie Leukemia Screening Product
Table 70. Abbvie Revenue in Leukemia Screening Business (2016-2021) & (US$ Million)
Table 71. Abbvie Recent Development
Table 72. GE Healthcare Company Details
Table 73. GE Healthcare Business Overview
Table 74. GE Healthcare Leukemia Screening Product
Table 75. GE Healthcare Revenue in Leukemia Screening Business (2016-2021) & (US$ Million)
Table 76. GE Healthcare Recent Development
Table 77. Siemens Healthcare Company Details
Table 78. Siemens Healthcare Business Overview
Table 79. Siemens Healthcare Leukemia Screening Product
Table 80. Siemens Healthcare Revenue in Leukemia Screening Business (2016-2021) & (US$ Million)
Table 81. Siemens Healthcare Recent Development
Table 82. Philips Healthcare Company Details
Table 83. Philips Healthcare Business Overview
Table 84. Philips Healthcare Leukemia Screening Product
Table 85. Philips Healthcare Revenue in Leukemia Screening Business (2016-2021) & (US$ Million)
Table 86. Philips Healthcare Recent Development
Table 87. Canon Medical Systems Company Details
Table 88. Canon Medical Systems Business Overview
Table 89. Canon Medical Systems Leukemia Screening Product
Table 90. Canon Medical Systems Revenue in Leukemia Screening Business (2016-2021) & (US$ Million)
Table 91. Canon Medical Systems Recent Development
Table 92. Hitachi Medical Systems Company Details
Table 93. Hitachi Medical Systems Business Overview
Table 94. Hitachi Medical Systems Leukemia Screening Product
Table 95. Hitachi Medical Systems Revenue in Leukemia Screening Business (2016-2021) & (US$ Million)
Table 96. Hitachi Medical Systems Recent Development
Table 97. Varian Medical Systems Company Details
Table 98. Varian Medical Systems Business Overview
Table 99. Varian Medical Systems Revenue in Leukemia Screening Business (2016-2021) & (US$ Million)
Table 100. Varian Medical Systems Recent Development
Table 101. Shimadzu Corporation Company Details
Table 102. Shimadzu Corporation Business Overview
Table 103. Shimadzu Corporation Leukemia Screening Product
Table 104. Shimadzu Corporation Revenue in Leukemia Screening Business (2016-2021) & (US$ Million)
Table 105. Shimadzu Corporation Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Leukemia Screening Market Share by Type: 2020 VS 2027
Figure 2. Bone Marrow Aspiration and Biopsy Features
Figure 3. Chest X-Ray or Chest CAT Scan Features
Figure 4. Spinal Tap Features
Figure 5. Global Leukemia Screening Market Share by Application: 2020 VS 2027
Figure 6. Cancer Research Centers Case Studies
Figure 7. Diagnostic Laboratories Case Studies
Figure 8. Clinics Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Leukemia Screening Report Years Considered
Figure 11. Global Leukemia Screening Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Leukemia Screening Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Leukemia Screening Market Share by Regions: 2020 VS 2027
Figure 14. Global Leukemia Screening Market Share by Regions (2022-2027)
Figure 15. Global Leukemia Screening Market Share by Players in 2020
Figure 16. Global Top Leukemia Screening Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leukemia Screening as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Leukemia Screening Revenue in 2020
Figure 18. Global Leukemia Screening Revenue Market Share by Type (2016-2021)
Figure 19. Global Leukemia Screening Revenue Market Share by Type (2022-2027)
Figure 20. North America Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Leukemia Screening Market Share by Type (2016-2027)
Figure 22. North America Leukemia Screening Market Share by Application (2016-2027)
Figure 23. North America Leukemia Screening Market Share by Country (2016-2027)
Figure 24. United States Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Leukemia Screening Market Share by Type (2016-2027)
Figure 28. Europe Leukemia Screening Market Share by Application (2016-2027)
Figure 29. Europe Leukemia Screening Market Share by Country (2016-2027)
Figure 30. Germany Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Leukemia Screening Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Leukemia Screening Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Leukemia Screening Market Share by Region (2016-2027)
Figure 40. China Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Leukemia Screening Market Share by Type (2016-2027)
Figure 48. Latin America Leukemia Screening Market Share by Application (2016-2027)
Figure 49. Latin America Leukemia Screening Market Share by Country (2016-2027)
Figure 50. Mexico Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Leukemia Screening Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Leukemia Screening Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Leukemia Screening Market Share by Country (2016-2027)
Figure 56. Turkey Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Leukemia Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Abbott Revenue Growth Rate in Leukemia Screening Business (2016-2021)
Figure 60. Abbvie Revenue Growth Rate in Leukemia Screening Business (2016-2021)
Figure 61. GE Healthcare Revenue Growth Rate in Leukemia Screening Business (2016-2021)
Figure 62. Siemens Healthcare Revenue Growth Rate in Leukemia Screening Business (2016-2021)
Figure 63. Philips Healthcare Revenue Growth Rate in Leukemia Screening Business (2016-2021)
Figure 64. Canon Medical Systems Revenue Growth Rate in Leukemia Screening Business (2016-2021)
Figure 65. Hitachi Medical Systems Revenue Growth Rate in Leukemia Screening Business (2016-2021)
Figure 66. Varian Medical Systems Revenue Growth Rate in Leukemia Screening Business (2016-2021)
Figure 67. Shimadzu Corporation Revenue Growth Rate in Leukemia Screening Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed


【掲載企業】

Abbott、Abbvie、GE Healthcare、Siemens Healthcare、Philips Healthcare、Canon Medical Systems、Hitachi Medical Systems、Varian Medical Systems、Shimadzu Corporation

★調査レポート[世界の白血病治療市場規模・現状・予測2021-2027] (コード:QY21APR3402)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の白血病治療市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆